GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...
The 2021 EAN/PNS guideline task force was supported by the European Academy of Neurology, the Peripheral Nerve Society, the ...
Emerging data suggest a possible genetic contributor to CIDP. In a recent study, patients with CIDP had a high frequency of perforin gene variations that impair the function of cytotoxic T and ...
Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...